Clinical trial
Value of Chemokine Receptor CXCR4-targeting Molecular Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
NCT04504526 is registered in ClinicalTrials.gov with First Affiliated Hospital of Fujian Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Value of Chemokine Receptor CXCR4-targeting Molecular Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative Diseases
- Lead sponsor
- First Affiliated Hospital of Fujian Medical University
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- August 7, 2020
- Completion date
- December 31, 2027
- Enrollment
- 50 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.